US 9796756
Galactose cluster-pharmacokinetic modulator targeting moiety for siRNA
granted A61PA61P1/16A61P3/00
Quick answer
US patent 9796756 (Galactose cluster-pharmacokinetic modulator targeting moiety for siRNA) held by Arrowhead Pharmaceuticals, Inc. expires Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arrowhead Pharmaceuticals, Inc.
- Grant date
- Tue Oct 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P1/16, A61P3/00, A61P31/12